| Tuesday April 29, 2008 | |
| 6:00 p.m. | Welcome Reception |
| Wednesday April 30, 2008 | |
| 7:30-8:30 a.m. | Registration and Breakfast Reception |
| 8:30-8:45 a.m. | Welcome & Opening Remarks
Co-Chair: Baiju Shah President & CEO BioEnterprise |
| 8:35-8:45 a.m. | Healthcare Private Investing Trends
Co-Chair: Anthony Viscogliosi Principal Viscogliosi & Brothers, LLC |
| 8:45-9:30 a.m. |
Fireside Chat
Interviewer:
Anthony Viscogliosi Principal Viscogliosi & Brothers, LLC
Guest Speaker:
Jayson Pankin New Venture Creation Specialist Delphi Corporation |
| 9:30-10:30 a.m. | Panel Discussion:
Developing US Companies Overseas In light of country-by-country language barriers, differences in laws, regulations and varying business practices, this panel will critically examine how to effectively develop, build, and expand US healthcare companies in overseas markets. Moderator: Marc R. Viscogliosi Principal Viscogliosi & Brothers, LLC
Panelists:
Frank Kung Managing Partner Vivo Ventures Allison K. Nelson Vice-Consulate, Research & Development Officer UK Trade & Investment — British Consulate
Dean Banks
Vice President Highland Capital Partners
Jean-Pierre Novak
Vice President Invest in France Agency-French Embassy |
| 10:30-11:00 a.m. | Refreshments & Networking Break |
| 11:00-12:00 p.m. |
Panel Discussion:
Tapping Global Capital Financing bioscience companies and venture firms with foreign capital including industrial conglomerates, sovereign funds, family offices, and foreign exchanges. Moderator: Baiju Shah President & CEO BioEnterprise
Panelists:
Bruce Roberts Managing Director Roberts Mitani Ramsay Battin Director Arcapita Ventures
Gerald Turner
General Partner Seraphim Capital\Focus Enterprises
David Biondo
Senior VP Investment Banking Viscogliosi & Company Inc. |
| 12:00-1:45 p.m. | Luncheon with Keynote |
|
Keynote Address:
Global Arbitrage Opportunities in Biotech and Life Sciences The coming decade promises a transformation in healthcare and lifesciences. Factors that influence that ‘tipping point’ are: the advent of personalized medicine, moving from sickness to wellness, intense pressures on reducing cost of healthcare delivery, improving access to healthcare for underserved patients around the globe. Globalization will play a critical role in transforming healthcare in developed and developing nations. Although initially emerging economies will participate in lower value parts of the value chain (e.g., outsourcing of non-core processes), in time these will develop innovation-based biopharmaceutical and healthcare industries that will serve not only growing local markets, but capture global opportunity. This talk will examine the progress to date in the biotech industry in emerging markets, and will offer a perspective on how to best capture the value of global arbitrage opportunities in the near-term future. Carol Kovac Partner Burrill & Company |
|
| 1:45-3:30 p.m. | Emerging Company Presentations
The Conference Advisory Board has selected the following international, venture-backed, healthcare companies to present. All companies are looking for later-stage capital.
Time:
1:45-2:00 p.m. 2:00-2:15 p.m. 2:15-2:30 p.m. 2:30-2:45 p.m. 2:45-3:00 p.m. 3:00-3:15 p.m. 3:15-3:30 p.m.
Company:
Proxy Biomedical Limited Paradigm Spine, LLC Glycoscience Laboratories, Inc. CYTOX Limited Napo Pharmaceuticals, Inc. Small Bone Innovations, Inc. Evolva SA
Country:
Ireland Germany Japan England USA France Switzerland & India
Presenter:
Peter Gingras Marc Viscogliosi Akira Asari Richard Hadden Lisa Conte Anthony Viscogliosi Neil Goldsmith |
| 3:30-4:00 p.m. | Refreshments & Networking Break |
| 4:00-5:00 p.m. | Panel Discussion:
Opportunities in Emerging Geographies This session will discuss different opportunities within emerging geographies specifically biopharma, device, and hospital/service sectors. The following topics will be covered:
Moderator: Maureen Bennett Partner and Chair, Life Science Practice Squire, Sanders & Dempsey L.L.P.
Panelists:
Michael Goldberg Managing Partner Bridge Investment Fund L.P. Kevin Buckley Managing Director BioTactica Scott Weiner Principal Pappas Ventures |
| 5:00-6:00 p.m. | Panel Discussion:
Global Distribution Strategies Investors discuss challenges and strategies for introducing new medical products and therapies into various country markets including Western Europe, Eastern Europe, Asia, and the Middle East. Moderator: Len Cosentino Vice President and General Counsel NDI Medical, Inc.
Panelists:
Terence Bentley Senior Director of Corporate Development Teleflex Corporation Mark Maciejewski Senior VP International Investment NTEC, Kuwait
Tim Hansen
Director Jvax Investment Group
G. Garrett Vygantas
Senior Associate Burrill & Company |
| 6:00 p.m. | Cocktail Reception |
| 7:00 p.m. | Investors Dinner (Invitation only) |
| Thursday May 1, 2008 | |
| 7:00-8:00 a.m. | Breakfast & Networking Reception |
| 8:00-8:45 a.m. | The Nuts & Bolts of Technology Reimbursement
This workshop is intended to provide a brief overview of reimbursement concepts that affect medical technologies. Charles Schneider plans to discuss reimbursement value drivers typically evaluated during a due diligence review. Attendees will gain an understanding about the reimbursement process; and critical areas of reimbursement review required to properly evaluate a technology. Charles E. Schneider Vice President, Reimbursement Musculoskeletal Clinical Regulatory Advisers, LLC |
| 8:45-9:45 a.m. | Panel Discussion:
Is it the right time to be in Asia? Moderator: Vivian Lee Managing Director Aqua Partners LLC
Panelists:
Kent Gossett Principal SR One Sanuj K. Ravindran Principal Radius Ventures
Andrew Jay
Managing partner, Medical Solutions Fund Siemens Venture Capital, Inc.
Anthony Sun
Principal Aisling Capital |
| 9:55-11:40 a.m. | Emerging Company Presentations
Time:
9:55-10:10 a.m. 10:10-10:25 a.m 10:25-10:40 a.m 10:40-10:55 a.m. 10:55-11:10 a.m. 11:10-11:25 a.m. 11:25-11:40 a.m.
Company:
GammaStar Medical Group Ltd. EyePlusPlus, Inc. Scitech Produtos Medicos Ltda. Asklepion Pharmaceuticals, LLC Alvos Biotec m2m Imaging Corp
Country:
China Japan Brazil USA Brazil USA
Presenter:
Paul Murdoch Harlan Jacobs Melchiades Cunha Bo Allen C. Richard Hullihen |
| 11:40-12:25 p.m. | Getting Your Technology through the FDA
Deciding the best regulatory pathway for your device for marketing, while avoiding pitfalls of the regulatory process. Guest Speaker: Glenn Stiegman Vice President, Regulatory Affairs Musculoskeletal Clinical Regulatory Advisers, LLC |
| 12:30-1:30 p.m. | Working Luncheon |
| Bringing Companies into the US
This panel will focus on the challenges faced by investors in bringing their overseas venture start-ups into the US for clinical and market development. Moderator: Neil Goldsmith Managing Director & CEO Evolva SA
Panelists:
Ting Pau Oei Partner L Capital Leon Polott Founder & President 5iTech, LLC
Avshalom Horan
Managing Partner Bridge Investment Fund L.P.
David Tharp
Vice-Consulate & USA Lead Officer, Biotechnology & Pharmaceuticals UK Trade & Investment-British Consulate |
|
| 1:30 p.m. | Conference Adjourns |
Copyright © 2008 International Business Forum. All Rights Reserved.